biostudies-literaturePaudel RDana-Farber Cancer InstituteDartmouth Hitchcock Medical CenterLifespan Health SystemNational Cancer InstituteNCI NIH HHSNational Institutes of HealthBaptist Health SystemThe IMPACT Consortium is a Cancer Moonshot Research InitiativeNIH HHSWest Virginia University1137-1144https://www.ebi.ac.uk/biostudies/studies/S-EPMC11223809biostudies-literatureUnknown116(7)<h4>Background</h4>Optimal methods for deploying electronic patient-reported outcomes to manage symptoms in routine oncologic practice remain uncertain. The electronic symptom management (eSyM) program asks chemotherapy and surgery patients to self-report 12 common symptoms regularly. Feedback from nurses and patients led to changing the recall period from the past 7 days to the past 24 hours.<h4>Methods</h4>Using questionnaires submitted during the 16 weeks surrounding the recall period change, we assessed the likelihood of reporting severe or moderate and severe symptoms across 12 common symptoms and separately for the 5 most prevalent symptoms. Interrupted time-series analyses modeled the effects of the change using generalized linear mixed-effects models. Surgery and chemotherapy cohorJournal of the National Cancer InstituteEffects of a change in recall period on reporting severe symptoms: an analysis of a pragmatic multisite trial.PMC11223809UM1CA233080P30 CA008748T32 CA009172UM1 CA233080Jensen REMitchell SADizon DSCronin CHassett MJPaudel RBian JWong SLHazard Jenkins HSchrag DOsarogiagbon RUEnzinger ACUno HfalseEffects of a change in recall period on reporting severe symptoms: an analysis of a pragmatic multisite trial.<h4>Background</h4>Optimal methods for deploying electronic patient-reported outcomes to manage symptoms in routine oncologic practice remain uncertain. The electronic symptom management (eSyM) program asks chemotherapy and surgery patients to self-report 12 common symptoms regularly. Feedback from nurses and patients led to changing the recall period from the past 7 days to the past 24 hours.<h4>Methods</h4>Using questionnaires submitted during the 16 weeks surrounding the recall period change, we assessed the likelihood of reporting severe or moderate and severe symptoms across 12 common symptoms and separately for the 5 most prevalent symptoms. Interrupted time-series analyses modeled the effects of the change using generalized linear mixed-effects models. Surgery and chemotherapy cohor2024-01-01T00:00:00Z2024 Jul2026-06-01T09:24:54.39Z2025-04-04T12:21:39.938ZS-EPMC112238093844574410.1093/jnci/djae049